Cargando…
Pharmacological inhibition of MDM4 alleviates pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown etiology with no cure. A better understanding of the disease processes and identification of druggable targets will benefit the development of effective therapies for IPF. We previously reported that MDM4 promoted...
Autores principales: | Mei, Qianru, Yang, Zhenhua, Xiang, Zhengkai, Zuo, He, Zhou, Zijing, Dong, Xiaochuan, Zhang, Ludan, Song, Wenhui, Wang, Yi, Hu, Qinghua, Zhou, Yong, Qu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240813/ https://www.ncbi.nlm.nih.gov/pubmed/37284444 http://dx.doi.org/10.7150/thno.81993 |
Ejemplares similares
-
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
por: Mei, Qianru, et al.
Publicado: (2022) -
Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis
por: Xiong, Chongxiang, et al.
Publicado: (2016) -
Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescence
por: Zuo, Biao, et al.
Publicado: (2022) -
TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2
por: Lv, Xiaoxi, et al.
Publicado: (2023) -
Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice
por: Qu, Jing, et al.
Publicado: (2021)